You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 廣生堂午後拉昇逾6% 獲得索磷布韋片生產受理書
格隆匯 08-30 14:10
廣生堂(300436.SZ)午後拉昇,現報38.15元,漲6.48%,暫成交2.15億元,最新總市值53.4億元。廣生堂午間發佈公告稱,公司已完成索磷布韋片與原研藥品的體外質量與體內療效的一致性評價,即與原研藥體外藥學質量一致且人體生物等效。公司已向國家藥監局藥品審評中心遞交了生產註冊申請,並於8月30日(即今日)收到國家藥監局下發的《受理通知書》。索磷布韋是全球丙肝治癒的核心用藥。此外,廣生堂近日公佈,公司及控股子公司江蘇中興藥業共有29個藥品被納入國家醫保目錄,退出的藥品共4個。天風證券指相關納入醫保目錄的品種將十分有望迎來放量,同時接下來的醫保談判目錄將更加值得期待。(行情來源:富途證券)
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account